Connection

Charles Smith to Neovascularization, Pathologic

Back to Details
This is a "connection" page, showing publications Charles Smith has written about Neovascularization, Pathologic.
Charles Smith
Connection Strength
0.032
Neovascularization, Pathologic
  1. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin Cancer Res. 2008 Jun 01; 14(11):3571-81.
    View in: PubMed
    Score: 0.018
  2. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res. 2005 Mar 15; 65(6):2412-21.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.